Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Inhibition of glutamate carboxypeptidase II as a novel approach to diabetic retinopathy

Nov. 14, 2003

Lexicon moves into ophthalmology

Nov. 11, 2003

NDA accepted for antiinflammatory-antibiotic combination product

Nov. 7, 2003

AL-2512 as a potentially safer ocular antiinflammatory agent

Oct. 21, 2003

Visudyne approved in Japan for wet AMD

Oct. 20, 2003

Characterization of SU-10944, an orally active small-molecule inhibitor of VEGFR-2

Oct. 14, 2003

FDA accepts Vitrase NDA for filing

Oct. 10, 2003

Novartis presents new IOP-lowering agents in recent patent

Oct. 10, 2003

Improved vision observed in phase I/II trial of squalamine in wet AMD

Oct. 9, 2003

Integrin antagonists useful for angiogenesis-related ocular diseases

Sep. 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...